Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 59Lymphoid 58Sarcoma 10Genitourinary 7Breast 7Myeloid 5Classical hematology 4CNS 4Dermatologic 3Tumor-Agnostic 1Plasma cell 1Head & Neck 1Gynecologic 1

Conditions

Carcinoma 1

Interventions

regorafenib 2Radiotherapy 2Music Therapy 2Interviews as Topic 2Albumin-Bound Paclitaxel 2trifluridine tipiracil drug combination 1tremelimumab 1plozalizumab 1pegfilgrastim 1nintedanib 1merphos 1durvalumab 1cabozantinib 1Vinblastine 1Trifluridine 1Surveys and Questionnaires 1Standard of Care 1Spermine Synthase 1Radiosurgery 1Psychiatrists 1Psychiatric Rehabilitation 1Proton Therapy 1Prednisone 1Practice Guidelines as Topic 1Platinum 1Paclitaxel 1Oxycodone 1Oxaliplatin 1Olanzapine 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Methotrexate × Tumor-Agnostic × Clear all
NCT02412670 2023-07-10

Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
36 enrolled 14 charts
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡